Income Statement for Nymox Pharmaceutical Corp (NYMX)
| | | Income Statement for Nymox Pharmaceutical Corp. (NYMX) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 413 | 437 | 425 | 322 | 199 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (251) | (251) | (211) | (186) | (123) | | Gross Operating Profit | 162 | 186 | 214 | 136 | 76 | | | Selling/General/Admin Expense | (2,223) | (2,028) | (1,492) | (1,556) | (1,524) | | Research & Development | (2,730) | (2,541) | (1,829) | (1,852) | (2,477) | | EBITDA | (4,791) | (4,382) | (3,106) | (3,271) | (3,925) | | Depreciation & Amortization | (501) | (457) | (436) | (433) | (409) | | EBIT | (5,292) | (4,839) | (3,542) | (3,704) | (4,334) | | Interest Income | 21 | 5 | 2 | 0 | 1 | | Other Income, Net | - | - | - | - | - | | Total Income Avail For Interest Expense | (5,271) | (4,834) | (3,541) | (3,704) | (4,333) | | Interest Expense | (20) | (60) | (44) | (42) | (30) | | Pre-Tax Income | (5,290) | (4,894) | (3,585) | (3,746) | (4,364) | | Income Taxes | - | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (5,290) | (4,894) | (3,585) | (3,746) | (4,364) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (5,290) | (4,894) | (3,585) | (3,746) | (4,364) | | | Normalized Income | (5,290) | (4,894) | (3,585) | (3,746) | (4,364) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (5,290) | (4,894) | (3,585) | (3,746) | (4,364) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -0.18 | -0.18 | -0.14 | -0.15 | -0.18 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.18 | -0.18 | -0.14 | -0.15 | -0.18 | | | Diluted EPS from Continuing Operations | -0.18 | -0.18 | -0.14 | -0.15 | -0.18 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.18 | -0.18 | -0.14 | -0.15 | -0.18 | | | |
Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT Realtime, EOD End Of Day, PD Previous Day. Market Data powered by QuoteMedia, financials by Morningstar. Terms of Use. | |
| |
Research Report
Hotstocked.com has a complete research report available for NYMX stock.
Download NYMX report.
Research Report
Get the full report for FREE
| Date: | Sep 3, 2008 |
|---|
| Price: | Free |
|---|
| Pages: | 5 |
|---|
| Document Type: | Adobe Acrobat Reader |
|---|
| | Download NYMX report |
|---|
| | |
|---|
| Example preview: |
|
|
